UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases

Nature communications, 2019-11, Vol.10 (1), p.5108-15, Article 5108

2019

Volltextzugriff (PDF)

Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion

Nature nanotechnology, 2022-02, Vol.17 (2), p.206-216

2022

Volltextzugriff (PDF)

Long-Term Outcomes From a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2021-09, Vol.111 (1), p.152-156

2021

Volltextzugriff (PDF)

Adverse Event Reporting at Professional Conferences: We Need Better Standards and Bigger Posters

Journal of thoracic oncology, 2020-09, Vol.15 (9), p.1394-1396

2020

Volltextzugriff (PDF)

Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer

Journal of palliative medicine, 2023-06, Vol.26 (6), p.831

2023

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone

Clinical cancer research, 2009-12, Vol.15 (23), p.7398-7404

2009

Volltextzugriff (PDF)

Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1

Molecular cancer, 2018-04, Vol.17 (1), p.81-81, Article 81

2018

Volltextzugriff (PDF)

Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review

JAMA oncology, 2023-03, Vol.9 (3), p.419

2023

Volltextzugriff (PDF)

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1220-1226

2009

Volltextzugriff (PDF)

Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer

Oncotarget, 2016-12, Vol.7 (52), p.87124-87135

2016

Volltextzugriff (PDF)

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Journal of clinical oncology, 2012-11, Vol.30 (32), p.3953-3959

2012

Volltextzugriff (PDF)

Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial

The International journal of biological markers, 2019-03, Vol.34 (1), p.90-97

2019

Volltextzugriff (PDF)

Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

Sarcoma, 2016, Vol.2016, p.4592768-7

2016

Volltextzugriff (PDF)

A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

Clinical cancer research, 2007-03, Vol.13 (6), p.1794-1800

2007

Volltextzugriff (PDF)

Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center

Cancer epidemiology, biomarkers & prevention, 2015-04, Vol.24 (4), p.664-670

2015

Volltextzugriff (PDF)

Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer

Nano research, 2023-04, Vol.16 (4), p.5300-5310

2023

Volltextzugriff (PDF)

Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke

Lung cancer (Amsterdam, Netherlands), 2010-01, Vol.67 (1), p.12-16

2010

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

Clinical cancer research, 2004-11, Vol.10 (22), p.7547-7554

2004

Volltextzugriff (PDF)

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer

Lung cancer (Amsterdam, Netherlands), 2011-12, Vol.74 (3), p.384-391

2011

Volltextzugriff (PDF)

The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening

Chest, 2023-08, Vol.164 (2), p.531-543

2023

Volltextzugriff (PDF)

Bexarotene and Erlotinib for Aerodigestive Tract Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8757-8764

2005

Volltextzugriff (PDF)

Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.527-535

2018

Volltextzugriff (PDF)

Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non–Small-Cell Lung Cancer in Clinical Practice

Clinical lung cancer, 2020-05, Vol.21 (3), p.255-263.e4

2020

Volltextzugriff (PDF)

Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2020-07, Vol.21 (4), p.e286-e293

2020

Volltextzugriff (PDF)

Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-09, Vol.159, p.56-65

2021

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(52)
Humans
(47)
Oncology
(35)
Male
(22)
Female
(21)
Middle Aged
(20)
Biological And Medical Sciences
(18)
Aged
(17)
Medical Sciences
(17)
Tumors
(14)
Lung Neoplasms - Drug Therapy
(13)
Adult
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Lung Cancer
(11)
Lung Neoplasms - Pathology
(11)
Aged, 80 And Over
(10)
Animals
(9)
Respiratory System
(9)
Biomarkers, Tumor - Metabolism
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Lung Cancer
(5)
Lung Cancer
(5)
Clinical Cancer Research
(4)
Cancer Research
(3)
Journal Of Clinical Oncology
(3)
Virology
(3)
Advanced Materials
(2)
Bmc Cancer
(2)
Cancer
(2)
Cancer Epidemiology, Biomarkers & Prevention
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases

Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion

Long-Term Outcomes From a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer

Adverse Event Reporting at Professional Conferences: We Need Better Standards and Bigger Posters

Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer

Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone

Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1

Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers

Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial

Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial

Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center

Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer

Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer

The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening

Bexarotene and Erlotinib for Aerodigestive Tract Cancer

Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer

Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non–Small-Cell Lung Cancer in Clinical Practice

Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer

Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer

Suchergebnisse filtern